Since we have shown the critical role for endogenous MDA in NASH and P2-BSA immunization raised IgM antibody levels toward MDA, these mimotopes are a promising tool to induce immunity against this relevant antigen to reduce/prevent NAFLD progression (46). Here, CD40LG is linked to metabolic dysfunction-associated steatotic liver disease.